Antimicrobial Resistance in the Post-COVID Era: A Silent Pandemic
A special issue of Pathogens (ISSN 2076-0817).
Deadline for manuscript submissions: 31 March 2025 | Viewed by 662
Special Issue Editors
Interests: viral infections; HIV/AIDS; SARS-CoV-2; antimicrobial resistance; antibiotics; antiviral agents
Interests: medical microbiology; antimicrobial resistance; biofilms
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The COVID-19 pandemic, caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), spread rapidly and the pressure in healthcare systems led to the limited role of infectious diseases control groups and antibiotic stewardship programs, increased rates of irrational use of antibiotic agents, and an increased incidence of multidrug-resistance (MDR) infections. The rise in MDR infections threatens public heath, leading to high rates of morbidity, mortality, and economic loss. Antimicrobial resistance (AMR) is defined as an increasing resistance to antibiotics, reducing the ability to treat common and serious infectious diseases. Empowering infectious disease surveillance programs and committees is vital to reduce the irrational use of antibiotics and the impact of infections by multidrug-resistant microorganisms.
I would like to invite colleagues investigating the mechanisms of AMR, the prevalence and risk factors of MDR infections, and the role of antibiotic stewardship programs to submit their manuscripts to this Special Issue in the form of original research and reviews.
Dr. Vasileios Petrakis
Dr. Maria Panopoulou
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- COVID-19 pandemic
- antimicrobial resistance
- bloodstream infections
- multidrug-resistant bacteria
- infection prevention and control group
- antibiotic stewardship
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
